AI Article Synopsis

  • p21 is a strong inhibitor of cyclin-dependent kinases that can stop cell cycle progression, primarily regulated by transcription factors like p53.
  • Researchers found that E2F transcription factors can activate p21 without p53, leading them to create cell lines with tamoxifen-dependent E2F-1.
  • They discovered that increased E2F-1 activity could significantly halt cells in the S phase of the cycle by boosting p21 protein levels, suggesting p21 helps prevent uncontrolled cell growth, particularly when E2F is activated by oncogenic processes.

Article Abstract

p21 is a potent inhibitor of cyclin-dependent kinases capable of arresting cell cycle progression. p21 is primarily regulated at the transcriptional level by several transcription factors, including p53. Previously, we reported that certain members of the E2F family of transcription factors may activate p21 transcription via a p53-independent mechanism. To further elucidate the consequences of E2F-1-regulated induction of p21, we developed cell lines with a tamoxifen-dependent form of E2F-1. We confirmed direct interaction of E2F-1 with the proximal region of the p21 promoter. Interestingly, elevated E2F-1 activity was sufficient to arrest a substantial subset of cells in S phase and this effect was correlated to and dependent on the induction of p21 protein. Since E2F proteins control genes required for cell cycle progression and are activated by various oncogenic events, we believe that the p21-dependent arrest described in this report represents an additional mechanism that guards against unrestricted cell proliferation.

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1207571DOI Listing

Publication Analysis

Top Keywords

cell cycle
16
cycle progression
8
transcription factors
8
induction p21
8
cell
6
p21
6
constitutive expression
4
e2f-1
4
expression e2f-1
4
e2f-1 leads
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!